Skip to main content
Top
Published in: BMC Public Health 1/2018

Open Access 01-12-2018 | Research article

High-resolution epidemic simulation using within-host infection and contact data

Authors: Van Kinh Nguyen, Rafael Mikolajczyk, Esteban Abelardo Hernandez-Vargas

Published in: BMC Public Health | Issue 1/2018

Login to get access

Abstract

Background

Recent epidemics have entailed global discussions on revamping epidemic control and prevention approaches. A general consensus is that all sources of data should be embraced to improve epidemic preparedness. As a disease transmission is inherently governed by individual-level responses, pathogen dynamics within infected hosts posit high potentials to inform population-level phenomena. We propose a multiscale approach showing that individual dynamics were able to reproduce population-level observations.

Methods

Using experimental data, we formulated mathematical models of pathogen infection dynamics from which we simulated mechanistically its transmission parameters. The models were then embedded in our implementation of an age-specific contact network that allows to express individual differences relevant to the transmission processes. This approach is illustrated with an example of Ebola virus (EBOV).

Results

The results showed that a within-host infection model can reproduce EBOV’s transmission parameters obtained from population data. At the same time, population age-structure, contact distribution and patterns can be expressed using network generating algorithm. This framework opens a vast opportunity to investigate individual roles of factors involved in the epidemic processes. Estimating EBOV’s reproduction number revealed a heterogeneous pattern among age-groups, prompting cautions on estimates unadjusted for contact pattern. Assessments of mass vaccination strategies showed that vaccination conducted in a time window from five months before to one week after the start of an epidemic appeared to strongly reduce epidemic size. Noticeably, compared to a non-intervention scenario, a low critical vaccination coverage of 33% cannot ensure epidemic extinction but could reduce the number of cases by ten to hundred times as well as lessen the case-fatality rate.

Conclusions

Experimental data on the within-host infection have been able to capture upfront key transmission parameters of a pathogen; the applications of this approach will give us more time to prepare for potential epidemics. The population of interest in epidemic assessments could be modelled with an age-specific contact network without exhaustive amount of data. Further assessments and adaptations for different pathogens and scenarios to explore multilevel aspects in infectious diseases epidemics are underway.
Appendix
Available only for authorised users
Literature
2.
3.
go back to reference Lofgren ET, Halloran ME, Rivers CM, Drake JM, Porco TC, Lewis B, Yang W, Vespignani A, Shaman J, Eisenberg JN, Eisenberg MC, Marathe M, Scarpino SV, Alexander KA, Meza R, Ferrari MJ, Hyman JM, Meyers LA, Eubank S. Opinion: Mathematical models: a key tool for outbreak response. Proc Natl Acad Sci USA. 2014; 111(51):18095–6.CrossRefPubMed Lofgren ET, Halloran ME, Rivers CM, Drake JM, Porco TC, Lewis B, Yang W, Vespignani A, Shaman J, Eisenberg JN, Eisenberg MC, Marathe M, Scarpino SV, Alexander KA, Meza R, Ferrari MJ, Hyman JM, Meyers LA, Eubank S. Opinion: Mathematical models: a key tool for outbreak response. Proc Natl Acad Sci USA. 2014; 111(51):18095–6.CrossRefPubMed
5.
go back to reference Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. Oxford: OUP Oxford; 1992. Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. Oxford: OUP Oxford; 1992.
6.
go back to reference Heesterbeek H, Anderson RM, Andreasen V, Bansal S, De Angelis D, Dye C, Eames KTD, Edmunds WJ, Frost SDW, Funk S, Hollingsworth TD, House T, Isham V, Klepac P, Lessler J, Lloyd-Smith JO, Metcalf CJE, Mollison D, Pellis L, Pulliam JRC, Roberts MG, Viboud C. Modeling infectious disease dynamics in the complex landscape of global health. Science. 2015; 347(6227):4339–9. https://doi.org/10.1126/science.aaa4339.CrossRef Heesterbeek H, Anderson RM, Andreasen V, Bansal S, De Angelis D, Dye C, Eames KTD, Edmunds WJ, Frost SDW, Funk S, Hollingsworth TD, House T, Isham V, Klepac P, Lessler J, Lloyd-Smith JO, Metcalf CJE, Mollison D, Pellis L, Pulliam JRC, Roberts MG, Viboud C. Modeling infectious disease dynamics in the complex landscape of global health. Science. 2015; 347(6227):4339–9. https://​doi.​org/​10.​1126/​science.​aaa4339.CrossRef
10.
go back to reference Merler S, Ajelli M, Fumanelli L, Parlamento S, Pastore Y Piontti A, Dean NE, Putoto G, Carraro D, Longini IM, Halloran ME, Vespignani A. Containing Ebola at the Source with Ring Vaccination. PLoS Negl Trop Dis. 2016; 10(11):0005093.CrossRef Merler S, Ajelli M, Fumanelli L, Parlamento S, Pastore Y Piontti A, Dean NE, Putoto G, Carraro D, Longini IM, Halloran ME, Vespignani A. Containing Ebola at the Source with Ring Vaccination. PLoS Negl Trop Dis. 2016; 10(11):0005093.CrossRef
11.
go back to reference Lukens S, DePasse J, Rosenfeld R, Ghedin E, Mochan E, Brown ST, Grefenstette J, Burke DS, Swigon D, Clermont G. A large-scale immuno-epidemiological simulation of influenza A epidemics. BMC Public Health. 2014; 14:1019.CrossRefPubMedPubMedCentral Lukens S, DePasse J, Rosenfeld R, Ghedin E, Mochan E, Brown ST, Grefenstette J, Burke DS, Swigon D, Clermont G. A large-scale immuno-epidemiological simulation of influenza A epidemics. BMC Public Health. 2014; 14:1019.CrossRefPubMedPubMedCentral
12.
go back to reference World Health Organization. Outbreak communication: Best practices for communicating with the public during an outbreak. Technical report. World Health Organization. Outbreak communication: Best practices for communicating with the public during an outbreak. Technical report.
16.
go back to reference Handel A, Rohani P. Crossing the scale from within-host infection dynamics to between-host transmission fitness: a discussion of current assumptions and knowledge. Philos Trans R Soc Lond B Biol Sci. 2015;370(1675). Handel A, Rohani P. Crossing the scale from within-host infection dynamics to between-host transmission fitness: a discussion of current assumptions and knowledge. Philos Trans R Soc Lond B Biol Sci. 2015;370(1675).
17.
go back to reference Alizon S, Luciani F, Regoes RR. Epidemiological and clinical consequences of within-host evolution. Trends Microbiol. 2011; 19(1):24–32.CrossRefPubMed Alizon S, Luciani F, Regoes RR. Epidemiological and clinical consequences of within-host evolution. Trends Microbiol. 2011; 19(1):24–32.CrossRefPubMed
18.
go back to reference Chen SC, Chio CP, Jou LJ, Liao CM. Viral kinetics and exhaled droplet size affect indoor transmission dynamics of influenza infection. Indoor Air. 2009; 19(5):401–13.CrossRefPubMed Chen SC, Chio CP, Jou LJ, Liao CM. Viral kinetics and exhaled droplet size affect indoor transmission dynamics of influenza infection. Indoor Air. 2009; 19(5):401–13.CrossRefPubMed
19.
go back to reference Farber DL, Yudanin NA, Restifo NP. Human memory T cells: generation, compartmentalization and homeostasis. Nat Rev Immunol. 2014; 14(1):24–35.CrossRefPubMed Farber DL, Yudanin NA, Restifo NP. Human memory T cells: generation, compartmentalization and homeostasis. Nat Rev Immunol. 2014; 14(1):24–35.CrossRefPubMed
20.
go back to reference Hernandez-Vargas EA, Wilk E, Canini L, Toapanta FR, Binder SC, Uvarovskii A, Ross TM, Guzman CA, Perelson AS, Meyer-Hermann M. Effects of aging on influenza virus infection dynamics. J. Virol. 2014; 88(8):4123–31.CrossRefPubMedPubMedCentral Hernandez-Vargas EA, Wilk E, Canini L, Toapanta FR, Binder SC, Uvarovskii A, Ross TM, Guzman CA, Perelson AS, Meyer-Hermann M. Effects of aging on influenza virus infection dynamics. J. Virol. 2014; 88(8):4123–31.CrossRefPubMedPubMedCentral
25.
go back to reference Day T, Alizon S, Mideo N. Bridging scales in the evolution of infectious disease life histories: theory. Evolution. 2011; 65(12):3448–61.CrossRefPubMed Day T, Alizon S, Mideo N. Bridging scales in the evolution of infectious disease life histories: theory. Evolution. 2011; 65(12):3448–61.CrossRefPubMed
26.
go back to reference Longini IM, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DA, Halloran ME. Containing pandemic influenza at the source. Science. 2005; 309(5737):1083–7.CrossRefPubMed Longini IM, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DA, Halloran ME. Containing pandemic influenza at the source. Science. 2005; 309(5737):1083–7.CrossRefPubMed
27.
go back to reference Cen X, Feng Z, Zhao Y. Emerging disease dynamics in a model coupling within-host and between-host systems. J Theor Biol. 2014; 361:141–51.CrossRefPubMed Cen X, Feng Z, Zhao Y. Emerging disease dynamics in a model coupling within-host and between-host systems. J Theor Biol. 2014; 361:141–51.CrossRefPubMed
31.
go back to reference Pastor-Satorras R, Vespignani A. Epidemic spreading in scale-free networks. Phys Rev Let. 2001; 86:3200–3. 0010317.CrossRef Pastor-Satorras R, Vespignani A. Epidemic spreading in scale-free networks. Phys Rev Let. 2001; 86:3200–3. 0010317.CrossRef
34.
go back to reference Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, Heijne J, Sadkowska-Todys M, Rosinska M, Edmunds WJ. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008; 5(3):74.CrossRef Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, Heijne J, Sadkowska-Todys M, Rosinska M, Edmunds WJ. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008; 5(3):74.CrossRef
35.
go back to reference Horby P, Pham QT, Hens N, Nguyen TT, Le QM, Dang DT, Nguyen ML, Nguyen TH, Alexander N, Edmunds WJ, Tran ND, Fox A, Nguyen TH. Social contact patterns in Vietnam and implications for the control of infectious diseases. PLoS ONE. 2011; 6(2):16965.CrossRef Horby P, Pham QT, Hens N, Nguyen TT, Le QM, Dang DT, Nguyen ML, Nguyen TH, Alexander N, Edmunds WJ, Tran ND, Fox A, Nguyen TH. Social contact patterns in Vietnam and implications for the control of infectious diseases. PLoS ONE. 2011; 6(2):16965.CrossRef
36.
37.
go back to reference Pellis L, Ball F, Bansal S, Eames K, House T, Isham V, Trapman P. Eight challenges for network epidemic models. Epidemics. 2015; 10:58–62.CrossRefPubMed Pellis L, Ball F, Bansal S, Eames K, House T, Isham V, Trapman P. Eight challenges for network epidemic models. Epidemics. 2015; 10:58–62.CrossRefPubMed
42.
go back to reference Prescott JB, Marzi A, Safronetz D, Robertson SJ, Feldmann H, Best SM. Immunobiology of Ebola and Lassa virus infections. Nat Rev Immunol. 2017; 17(3):195–207.CrossRefPubMed Prescott JB, Marzi A, Safronetz D, Robertson SJ, Feldmann H, Best SM. Immunobiology of Ebola and Lassa virus infections. Nat Rev Immunol. 2017; 17(3):195–207.CrossRefPubMed
43.
go back to reference Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, Fausther-Bovendo H, Wei H, Aviles J, Hiatt E, Johnson A, Morton J, Swope K, Bohorov O, Bohorova N, Goodman C, Kim D, Pauly MH, Velasco J, Pettitt J, Olinger GG, Whaley K, Xu B, Strong JE, Zeitlin L, Kobinger GP. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature. 2014; 514(7520):47–53.CrossRefPubMedPubMedCentral Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, Fausther-Bovendo H, Wei H, Aviles J, Hiatt E, Johnson A, Morton J, Swope K, Bohorov O, Bohorova N, Goodman C, Kim D, Pauly MH, Velasco J, Pettitt J, Olinger GG, Whaley K, Xu B, Strong JE, Zeitlin L, Kobinger GP. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature. 2014; 514(7520):47–53.CrossRefPubMedPubMedCentral
44.
go back to reference Marzi A, Robertson SJ, Haddock E, Feldmann F, Hanley PW, Scott DP, Strong JE, Kobinger G, Best SM, Feldmann H. EBOLA VACCINE, VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain. Science. 2015; 349(6249):739–42.CrossRefPubMed Marzi A, Robertson SJ, Haddock E, Feldmann F, Hanley PW, Scott DP, Strong JE, Kobinger G, Best SM, Feldmann H. EBOLA VACCINE, VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain. Science. 2015; 349(6249):739–42.CrossRefPubMed
45.
go back to reference Nowak M, May RM. Virus Dynamics : Mathematical Principles of Immunology and Virology: Mathematical Principles of Immunology and Virology. Oxford: Oxford University Press; 2000. Nowak M, May RM. Virus Dynamics : Mathematical Principles of Immunology and Virology: Mathematical Principles of Immunology and Virology. Oxford: Oxford University Press; 2000.
47.
go back to reference Madelain V, Nguyen TH, Olivo A, de Lamballerie X, Guedj J, Taburet AM, Mentre F. Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials. Clin Pharmacokinet. 2016; 55(8):907–23.CrossRefPubMedPubMedCentral Madelain V, Nguyen TH, Olivo A, de Lamballerie X, Guedj J, Taburet AM, Mentre F. Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials. Clin Pharmacokinet. 2016; 55(8):907–23.CrossRefPubMedPubMedCentral
48.
go back to reference Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Gsell PS, Hossmann S, Watle SV, Konde MK, Keita S, Kone S, Kuisma E, Levine MM, Mandal S, Mauget T, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Rottingen JA, Kieny MP. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet. 2017; 389(10068):505–18.CrossRefPubMedPubMedCentral Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Gsell PS, Hossmann S, Watle SV, Konde MK, Keita S, Kone S, Kuisma E, Levine MM, Mandal S, Mauget T, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Rottingen JA, Kieny MP. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet. 2017; 389(10068):505–18.CrossRefPubMedPubMedCentral
49.
go back to reference Li J, Duan HJ, Chen HY, Ji YJ, Zhang X, Rong YH, Xu Z, Sun LJ, Zhang JY, Liu LM, Jin B, Zhang J, Du N, Su HB, Teng GJ, Yuan Y, Qin EQ, Jia HJ, Wang S, Guo TS, Wang Y, Mu JS, Yan T, Li ZW, Dong Z, Nie WM, Jiang TJ, Li C, Gao XD, Ji D, Zhuang YJ, Li L, Wang LF, Li WG, Duan XZ, Lu YY, Sun ZQ, Kanu AB, Koroma SM, Zhao M, Ji JS, Wang FS. Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients. Int J Infect Dis. 2016; 42:34–9.CrossRefPubMed Li J, Duan HJ, Chen HY, Ji YJ, Zhang X, Rong YH, Xu Z, Sun LJ, Zhang JY, Liu LM, Jin B, Zhang J, Du N, Su HB, Teng GJ, Yuan Y, Qin EQ, Jia HJ, Wang S, Guo TS, Wang Y, Mu JS, Yan T, Li ZW, Dong Z, Nie WM, Jiang TJ, Li C, Gao XD, Ji D, Zhuang YJ, Li L, Wang LF, Li WG, Duan XZ, Lu YY, Sun ZQ, Kanu AB, Koroma SM, Zhao M, Ji JS, Wang FS. Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients. Int J Infect Dis. 2016; 42:34–9.CrossRefPubMed
50.
51.
go back to reference Feldmann H, Geisbert TW. Ebola haemorrhagic fever,. Lancet (London, England). 2011; 377(9768):849–62.CrossRef Feldmann H, Geisbert TW. Ebola haemorrhagic fever,. Lancet (London, England). 2011; 377(9768):849–62.CrossRef
52.
go back to reference Akerlund E, Prescott J, Tampellini L. Shedding of Ebola virus in an asymptomatic pregnant woman,. N Engl J Med. 2015; 372(25):2467–9.CrossRefPubMed Akerlund E, Prescott J, Tampellini L. Shedding of Ebola virus in an asymptomatic pregnant woman,. N Engl J Med. 2015; 372(25):2467–9.CrossRefPubMed
53.
go back to reference Statistics Sierra Leone (SSL) and ICF International. Sierra Leone Demographic and Health Survey 2013: Freetown, Sierra Leone and Rockville, Maryland, USA: SSL and ICF International; 2014. Statistics Sierra Leone (SSL) and ICF International. Sierra Leone Demographic and Health Survey 2013: Freetown, Sierra Leone and Rockville, Maryland, USA: SSL and ICF International; 2014.
56.
go back to reference Funk S, Bansal S, Bauch CT, Eames KT, Edmunds WJ, Galvani AP, Klepac P. Nine challenges in incorporating the dynamics of behaviour in infectious diseases models. Epidemics. 2015; 10:21–25.CrossRefPubMed Funk S, Bansal S, Bauch CT, Eames KT, Edmunds WJ, Galvani AP, Klepac P. Nine challenges in incorporating the dynamics of behaviour in infectious diseases models. Epidemics. 2015; 10:21–25.CrossRefPubMed
59.
go back to reference Csardi G, Nepusz T. The igraph software package for complex network research. InterJournal. 2006; Complex Systems:1695. Csardi G, Nepusz T. The igraph software package for complex network research. InterJournal. 2006; Complex Systems:1695.
60.
go back to reference World Health Organization. List of Blueprint priority diseases. Cambridge: WHO; 2018. World Health Organization. List of Blueprint priority diseases. Cambridge: WHO; 2018.
61.
go back to reference Csardi G, Nepusz T. The igraph software package for complex network research. InterJournal. 2006; Complex Systems:1695. Csardi G, Nepusz T. The igraph software package for complex network research. InterJournal. 2006; Complex Systems:1695.
63.
go back to reference World Health Organization. Immunization Coverage: Geneva: World Health Organization; 2010. World Health Organization. Immunization Coverage: Geneva: World Health Organization; 2010.
64.
go back to reference Keeling MJ, Rohani P. Modeling Infectious Diseases in Humans and Animals. Princeton: Princeton University Press; 2011. Keeling MJ, Rohani P. Modeling Infectious Diseases in Humans and Animals. Princeton: Princeton University Press; 2011.
66.
go back to reference Centers for Disease Control and Prevention and World Health Organization. Implementation and Management of Contact Tracing for Ebola Virus Disease: Emergency Guideline. 2015. Centers for Disease Control and Prevention and World Health Organization. Implementation and Management of Contact Tracing for Ebola Virus Disease: Emergency Guideline. 2015.
69.
go back to reference Virlogeux V, Fang VJ, Park M, Wu JT, Cowling BJ. Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia. Sci Rep. 2016; 6:35839.CrossRefPubMedPubMedCentral Virlogeux V, Fang VJ, Park M, Wu JT, Cowling BJ. Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia. Sci Rep. 2016; 6:35839.CrossRefPubMedPubMedCentral
71.
go back to reference Pastor-Satorras R, Castellano C, Van Mieghem P, Vespignani A. Epidemic processes in complex networks. Rev Mod Phys. 2015; 87(3):925.CrossRef Pastor-Satorras R, Castellano C, Van Mieghem P, Vespignani A. Epidemic processes in complex networks. Rev Mod Phys. 2015; 87(3):925.CrossRef
72.
go back to reference Bisset KR, Chen J, Feng X, Kumar VSA, Marathe MV. EpiFast: a Fast Algorithm for Large Scale Realistic Epidemic Simulations on Distributed Memory Systems. a fast algorithm for large scale realistic epidemic simulations on distributed memory systems. New York, New York, USA: ACM; 2009. https://doi.org/10.1145/1542275.1542336.CrossRef Bisset KR, Chen J, Feng X, Kumar VSA, Marathe MV. EpiFast: a Fast Algorithm for Large Scale Realistic Epidemic Simulations on Distributed Memory Systems. a fast algorithm for large scale realistic epidemic simulations on distributed memory systems. New York, New York, USA: ACM; 2009. https://​doi.​org/​10.​1145/​1542275.​1542336.CrossRef
73.
go back to reference Heffernan JM, Smith RJ, Wahl LM. Perspectives on the basic reproductive ratio. Journal of The Royal Society Interface. 2005; 2(4):281–293.CrossRefPubMedCentral Heffernan JM, Smith RJ, Wahl LM. Perspectives on the basic reproductive ratio. Journal of The Royal Society Interface. 2005; 2(4):281–293.CrossRefPubMedCentral
76.
go back to reference Abbas AK. B Cell Activation and Antibody Production. In: Cellular and Molecular Immunology. Elsevier Health Sciences: 2011. p. 1–26. Abbas AK. B Cell Activation and Antibody Production. In: Cellular and Molecular Immunology. Elsevier Health Sciences: 2011. p. 1–26.
78.
go back to reference Bowman A, Azzalini A. R Package sm: Nonparametric Smoothing Methods (version 2.2-5.4). 2014. Bowman A, Azzalini A. R Package sm: Nonparametric Smoothing Methods (version 2.2-5.4). 2014.
79.
go back to reference Van Kerkhove MD, Bento AI, Mills HL, Ferguson NM, Donnelly CA. A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making. Sci Data. 2015; 2:150019.CrossRefPubMedPubMedCentral Van Kerkhove MD, Bento AI, Mills HL, Ferguson NM, Donnelly CA. A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making. Sci Data. 2015; 2:150019.CrossRefPubMedPubMedCentral
Metadata
Title
High-resolution epidemic simulation using within-host infection and contact data
Authors
Van Kinh Nguyen
Rafael Mikolajczyk
Esteban Abelardo Hernandez-Vargas
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2018
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-018-5709-x

Other articles of this Issue 1/2018

BMC Public Health 1/2018 Go to the issue